Asset Details
Do you wish to reserve the book?
Involvement of Marinobufagenin in a Rat Model of Human Preeclampsia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Involvement of Marinobufagenin in a Rat Model of Human Preeclampsia
Do you wish to request the book?
Involvement of Marinobufagenin in a Rat Model of Human Preeclampsia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Involvement of Marinobufagenin in a Rat Model of Human Preeclampsia
2005
Overview
Background: Preeclampsia is a potentially devastating disorder of hypertension in pregnancy for which there is currently no definitive treatment short of delivery. The bufadienolide, marinobufagenin (MBG), an inhibitor of Na + /K + ATPase, has been found to be elevated in extracellular fluid volume-expanded hypertensive patients, a condition similar to preeclampsia. Thus, these studies sought to examine the role of MBG in our rat model of preeclampsia. Methods and Results: Pregnant female rats were injected intraperitoneally with deoxycorticosterone acetate (DOCA) and given 0.9% saline as drinking water for the duration of their pregnancy. Urinary MBG was measured using a DELFIA immunoassay. Blood pressure was measured via the tail-cuff method. Injections of anti-MBG antibody were given intraperitoneally or intravenously to hypertensive pregnant rats. MBG was given intraperitoneally to pregnant rats. Uterine arterioles were dissected free and their diameters were measured before and after perfusion of MBG, ouabain, or digoxin. MBG was found to be elevated in the pregnant + DOCA + saline (PDS) rats compared to normal pregnant animals. In addition, when PDS rats were injected with anti-MBG antibody, there was a subsequent reduction in blood pressure. Administration of MBG in normal pregnant rats caused an elevation in blood pressure equivalent to the PDS model. Also, uterine vessel measurements showed an increased vasoconstrictive reactivity to MBG in the PDS animals vs. the normal pregnant controls; while no changes were observed with perfusion of digoxin or ouabain at the same concentration. Conclusion: These results suggest a relationship between MBG and a syndrome in rats resembling preeclampsia. Armed with these promising results, it would seem logical to further examine the role of MBG in human preeclampsia.
Publisher
Karger,S. Karger AG
Subject
/ Antibodies - administration & dosage
/ Biological and medical sciences
/ Bufanolides - administration & dosage
/ Desoxycorticosterone - administration & dosage
/ Diseases of mother, fetus and pregnancy
/ Enzyme Inhibitors - administration & dosage
/ Enzyme Inhibitors - immunology
/ Female
/ Gynecology. Andrology. Obstetrics
/ Nephrology. Urinary tract diseases
/ Original Report: Laboratory Investigation
/ Pre-Eclampsia - chemically induced
/ Pre-Eclampsia - physiopathology
/ Rats
/ Sodium Chloride - administration & dosage
/ Sodium-Potassium-Exchanging ATPase - antagonists & inhibitors
